Journal Browser
Search
View All
Research on capacity building for high-quality development of Chinese medical journals: A comprehensive study of the journal China Oncology

Ming Ni1,2,3,*, Linhui Wang1,2,3, Guangtao Li1,2, Man Peng1,2, Hong Xu1,2

1Department of Editorial Office, Fudan University Shanghai Cancer Center, Shanghai 200032, China

2China Oncology Publishing House Co., Ltd., Shanghai 200032, China

3Biomedical Journal Professional Committee, Shanghai Society for Scientific & Technical Periodicals, Shanghai 200032, China



Editing Practice 2025, 3(1); https://doi.org/10.54844/ep.2025.0957
Submitted27 Mar 2026
Revised27 Mar 2026
Accepted27 Mar 2026
Published27 Mar 2026
+
Cite This Article
Abstract

Background: High-quality development and enhancement of global reputation are important for Chinese biomedical journals. This study analyzed the high-quality development status and strategies of China Oncology since the establishment of the Fifth Editorial Board, aiming to provide a reference for the high-quality development of biomedical journals in China. Methods: This study summarized all strategies adopted from 2020 to 2024 to enhance the competitiveness of China Oncology, including expanding the editorial board members, establishing policies, improving writing quality (following the Enhancing the QUAlity and Transparency Of health Research [EQUATOR] Network guidelines), performing the Principles of Transparency and Best Practice in Scholarly Publishing, and applying for inclusion in international databases. In addition, GraphPad Prism 10.0 was used for graphical analysis. Results: China Oncology enhanced global influence and contributed to the improvement of cancer prevention and treatment. China Oncology has strengthened various capacity building through multidimensional development and has achieved significant results in all aspects, including expanding the editorial board members and establishing a youth editorial board, strictly controlling the academic quality of journals, promoting journal transparency, carrying out an open-access (OA) publishing model with Creative Commons (CC) license CC BY-NC-ND 4.0, expanding inclusion in international databases (indexed by Scopus, Directory of Open Access Journals [DOAJ], Excerpta Medica Database [Embase], EBSCO, Japan Science and Technology [JST], and Index Copernicus), and enhancing content quality by following the EQUATOR Network guidelines. Conclusion: By applying for inclusion in renowned international databases, enhancing academic influence and international visibility by expanding the members of the editorial board, strictly following the EQUATOR Network guidelines and Principles of Transparency and Best Practice in Scholarly Publishing, strengthening publishing ethics, focusing on oncology hotspot studies, and improving the scientific and editorial quality of the manuscripts, Chinese medical journals can achieve high-quality development.

REFERENCES
  1. The Publicity Department of China Association for Science and Technology, Academic Department of China Association for Science and Technology. [Deepening reform and cultivating world-class scientific and technological journals]. China Association for Science and Technology. Updated August 16, 2019. Accessed July 15, 2025. http://www.cast.org.cn/xw/TTXW/art/2019/art_b5da1323b57c4d16b779172ad533cd88.html

  2. Hu XJ. [Development status and analysis of English medical journals in China oriented to world first-class scientific journals]. Chin J Sci Tech Period. 2024;35(4):532-540.    DOI: 10.11946/cjstp.202309180748

  3. DOAJ. Transparency & best practice. DOAJ. Accessed July 15, 2025. https://doaj.org/apply/transparency/

  4. Wang Y. [Updates of "Principles of Transparency and Best Practice in Scholarly Publishing" and implications for Chinese academic journals]. Chin J Sci Tech Period. 2024;35(8):1109-1115.    DOI: 10.11946/cjstp.202401220066

  5. EQUATOR Network guidelines. EQUATOR Network. Accessed July 15, 2025. https://www.equator-network.org/

  6. The ARRIVE Guidelines 2.0: Updated guidelines for reporting animal research. Equator network. Updated March 6, 2023. Accessed July 15, 2025. https://www.equator-network.org/reporting-guidelines/improving-bioscience-research-reporting-the-arrive-guidelines-for-reporting-animal-research/

  7. Yu XT, Zhang JY, Wang Y. [Updates of ICMJE recommendations from 2019 to 2021 and developing trends of medical journals]. Publ Print. 2022;(4):20-26.    DOI: 10.19619/j.issn.1007-1938.2022.00.033

  8. CONSORT 2025 Statement: updated guideline for reporting randomised trials. equator network. Updated April 18, 2025. Accessed July 25, 2025. https://www.equator-network.org/reporting-guidelines/consort/

  9. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. equator network. Updated March 6, 2023. Accessed July 25, 2025. https://www.equator-network.org/reporting-guidelines/strobe/

  10. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. equator network. Updated March 6, 2023. Accessed July 25, 2025. https://www.equator-network.org/reporting-guidelines/stard/

  11. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. equator network. Updated February 6, 2025. Accessed July 25, 2025. https://www.equator-network.org/reporting-guidelines/prisma/

  12. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. equator network. Updated November 15, 2021. Accessed July 25, 2025. https://www.equator-network.org/reporting-guidelines/the-agree-reporting-checklist-a-tool-to-improve-reporting-of-clinical-practice-guidelines/

  13. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. equator network. Updated April 2, 2024. Accessed July 25, 2025. https://www.equator-network.org/reporting-guidelines/care/

  14. Wang LH, Ni M. [Development status and countermeasures of China's Gold OA and Diamond OA journals: A study of the data from DOAJ]. Chin J Sci Tech Period. 2024;35(3):329-338.    DOI: 10.11946/cjstp.202311130911

  15. MEDLINE. Scientific and editorial quality assessment. National Library of Medicine. Updated May 2, 2024. Accessed July 15, 2025. https://www.nlm.nih.gov/medline/medline_journal_selection.html

  16. Manley S. Letters to the editor and the race for publication metrics. J Assoc Inf Sci Technol. 2022;73(5):702-707.    DOI: 10.1002/asi.24574

  17. Wang LH, Ni M, Li XW. The development status and countermeasures of biomedical OA journals in China: A study based on statistical analysis of the journal indexed data in PubMed central and DOAJ. J Sch Commun. 2025.    DOI: 10.62160/JSC26

  18. Liu J. Open access publishing in Singapore: Trends and policy perspectives. J Sch Commun. 2025;1:1-9.    DOI: 10.62160/JSC2

  19. Wang LH, Ni M. [An analysis of the strategies of Chinese open access journals applying for the DOAJ database]. Publ Print. 2022;(5):74-82.    DOI: 10.19619/j.issn.1007-1938.2022.00.066

  20. Ni M, Xu H, Wang XY, et al. [Practices and reflections on cultivating young editors in STM periodicals with a closed-loop "five-in-one: model: Experience from Shanghai Society for Scientific and Technical Periodicals]. Acta Ed. 2024;36(3):338-342.    DOI: 10.16811/j.cnki.1001-4314.2024.03.022

  21. Publicity Department of the Communist Party of China Central Committee, Ministry of Education, Ministry of Science and Technology. [Promoting the prosperity and development of academic journals]. Updated May 18, 2021. Accessed July 15, 2025. https://journals.xmu.edu.cn/download/xggf/guanyutuidongxueshuqikanfanrongfazhandeyijian.pdf

  22. Qin JH, Wang JJ, Ye FY. A Metric Approach to Hot Topics in Biomedicine via Keyword Co-occurrence. J Data Inform Sci. 2019;4(4):13-25.    DOI: 10.2478/jdis-2019-0018

  23. Moral-Munoz JA, Arroyo-Morales M, Piper BF, et al. Thematic Trends in Complementary and Alternative Medicine Applied in Cancer-Related Symptoms. J Data Inform Sci. 2019;4(4):13-25.    DOI: 10.2478/jdis-2018-0006

  24. Ni M, Wang LH, Li GT, et al. [Evaluation of guidelines and consensuses related to the diagnosis and treatment of breast cancer: based on the AGREE-China]. Chin Cancer. 2022;31(10):828-838.    DOI: 10.11735/j.issn.1004-0242.2022.09.A011

  25. Sun JF, Yang MQ. [Research on strategies of medical journal editors applying CONSORT to review RCT research papers]. Publ Print. 2022;(4):27-34.    DOI: 10.19619/j.issn.1007-1938.2022.00.059

  26. Wang YH, Xu H, Li DJ. [Interpretation and application suggestions on the Checklist for Artificial Intelligence in Medical Imaging (CLAIM): A guideline for authors and reviewers]. Publ Print. 2023;(6):89-95.    DOI: 10.19619/j.issn.1007-1938.2023.00.077

  27. Ding ZQ, Li CW. [The status and prospects of OA publishing in China as selected journals by the "China Science and Technology Journal Excellence Action Plan"]. Chin J Sci Tech Period. 2022;33(11):1561-1568.    DOI: 10.11946/cjstp.202204180288

  28. Deed. Attribution-nonCommercial-noDerivatives 4.0 international. Creative Commons website. Accessed July 15, 2025. https://creativecommons.org/licenses/by-nc-nd/4.0/deed.zh

  29. Ni M, Wang LH. [Current status and improvement strategies of copyright of biomedical open access journals in Shanghai, China]. Chin J Sci Tech Period. 2025;36(4):460-470.    DOI: 10.11946/cjstp.202405240554

  30. cOAlitions. Accelerating open access. 2021 annual review. Accessed July 15, 2025. https://www.coalition-s.org/wp-content/uploads/2022/01/Plan-S-annual-report-2021.pdf

  31. Liang Y, Yang Z, Tian H, Liu J, Li C, Dong W. The "Five Forces Model" and strategies for enhancing the influence of scientific journals. Ed Pract. 2024;2:6.    DOI: 10.54844/ep.2024.0795


Copyright: © by the authors. Licensee ISTS. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)
TOP